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Hyperlipidemia is the Best Predictor of the Need for Routine Coronary
Angiography in the Preoperative Evaluation of Chinese Patients
Undergoing Valve or Congenital Heart Surgery
JEFFREY W H FUNG AND JOHN E SANDERSON
From Division of Cardiology, Department of Medicine & Therapeutics, The Chinese University of Hong Kong,
Hong Kong

FUNG and SANDERSON: Hyperlipidemia is the Best Predictor of the Need for Routine Coronary Angiography
in the Preoperative Evaluation of Chinese Patients Undergoing Valve or Congenital Heart Surgery. Background:
Coronary angiography is commonly performed before cardiac surgery for patients with valvular and congenital
heart disease. However, the yield is not high. We hypothesized that risk factors analysis before angiography could
effectively select those patients who may have higher likelihood of coronary artery disease (CAD). Methods: Coronary
angiography was performed routinely in 243 patients with valvular or congenital heart disease prior to cardiac
surgery. Standard risk factors for coronary artery disease, age, sex, smoking history, chest pain, hypertension,
diabetes mellitus and hyperlipidemia (TC >5.2 mmol/l), and the results of angiography were analyzed retrospectively.
Results: The age range was 37 to 82 (mean 55 ± 11) and 120 were male. 23 patients (9.5%) had coronary artery
diseases, defined as > 50% stenosis detected angiographically in any of the epicardial arteries. Smokers (p=0.044),
patients with hypertension (p=0.004) or hyperlipidemia (p<0.001) had significantly higher incidence of CAD than
those without these risk factors. Sex, history of chest pain or diabetes mellitus were not significant risk factors. By
multivariate analysis, hyperlipidemia was a highly significant independent predictor for CAD (p<0.001). Correlation
coefficient between number of risk factors and presence of CAD was 0.418 (p<0.001). No patient who had none of
these risk factors had CAD. Only 11 patients had CABG done in addition to planned cardiac operation. By comparing
patients with or without CABG, hyperlipidemia was the only significant predictor for CAD (p<0.001). Conclusion:
In this pilot study we have found that in Chinese patients hyperlipidemia is the best predictor of CAD that requires
CABG, irrespective of age, sex, history of smoking, chest pain, hypertension or diabetes mellitus. Routine preoperative
coronary angiography is unnecessary in Chinese patients without risk factors for coronary artery disease. (J HK
Coll Cardiol 2000;8:122-128)
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Introduction

Methods

It is a common practice to have preoperative
coronary angiography as part of routine work-up for
patients undergoing valvular or congenital heart surgery.
As recommended by the ACC/AHA Task Force,
coronary angiography is indicated in patients with
valvular heart disease, who have chest discomfort,
evidence of ischemia and are of substantial age with
multiple risk factors.1 It is well known that the incidence
of coronary artery disease increases with age2 and varies
widely among different ethnic groups. Therefore, the
incidence of coronary artery disease in patients with
valvular or congenital heart disease will also be expected
to vary widely between different ethnic groups. In
Western populations, the incidence of coronary artery
disease in patients with or without valvular heart disease
is about the same frequency, about 30% 3-6 and the
prediction of coronary artery disease in patients
with valvular heart disease by risk factor analysis is
feasible.3,5 However, the prevalence of coronary artery
disease in Chinese population is different roughly onequarter, that of Western counterparts.7,8 Moreover, the
impact of the traditional risk factors for atherogenesis
in Chinese population seems to be less when compared
with that of Caucasians.9
Information about risk factor analysis in
predicting the incidence of coronary artery disease in
Chinese patients with valvular or congenital heart
diseases is scarce. Therefore, we have analysed the risk
factor profiles in a cohort of Chinese patients who had
coronary angiography performed as part of preoperative
evaluation. The purpose of this study was to evaluate
whether risk factor analysis could predict the presence of
coronary artery disease in Chinese patients with valvular
or congenital heart diseases preparing for cardiac surgery.
J HK Coll Cardiol, Vol 8

Patients
This is a retrospective analysis of 275 consecutive
patients with either valvular or congenital heart diseases
who had coronary angiography performed in our cardiac
catheterization laboratory as part of their preoperative
evaluation. The decision to perform coronary
angiography in these patients was made jointly by
cardiologists and cardiac surgeons. Patients with known
history of coronary artery disease e.g. old myocardial
infarction or previously angiographically diagnosed
coronary stenosis were excluded from analysis. Patients
were also excluded if the purpose of the coronary
angiography was to assess the severity of valvular or
congenital lesions or look for associated coronary
anomalies. A total of 243 patients were available for
analysis.

Cardiac Catheterization
Standard cardiac catheterization was performed
using femoral artery cannulation Coronary artery
disease was defined as any lesion in left main stem
artery, left anterior descending artery, left circumflex
artery and right coronary artery greater than 50%
stenosis by diameter. A simplified scoring system for
assessing severity of coronary artery disease was
adopted with 1 point for each diseased major epicardial
artery. The lowest score was 0 for patients without
coronary artery disease and maximum of 4 for patients
with coronary artery disease.

Risk Factors Analysis
The risk factors for coronary artery diseases used
for analysis in these patients with either valvular or
congenital heart diseases were: age, sex, hypertension,
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diabetes mellitus, and history of chest pain and
hyperlipidemia.
Hypertension was defined as blood pressure
measured on two different occasions with systolic
blood pressure >140 mmHg or diastolic blood pressure
>90 mmHg. Diabetes mellitus was defined as fasting
blood glucose >7.0 mmol/L. Hyperlipidemia was
defined as fasting total cholesterol >5.2 mmol/L or LDL
cholesterol >3.2 mmol/L. Chest pain was defined as
any recurrent retrosternal pain present before coronary
angiogram, either typical or atypical for angina.
Risk factor profiles were compared between
patients with or without coronary artery diseases and
patients with or without CABG performed. The
correlation between number of risk factors and the
severity of coronary artery disease was also assessed.

Statistics
Statistical analysis was performed by SYSTAT
7.0 for Windows software (SPSS Inc., Chicago). Results
were expressed as mean ± SD unless otherwise stated.
Predicting factors for co-existing coronary artery disease
and requirement of subsequent coronary arterial bypass
graft were determined by univariate analysis by
Student's t test and Chi-square test whenever
appropriate. Regression analysis for independent factors
was performed by backward stepwise elimination of
identified variables. All probabilities were two-tailed.

Results
There were 243 patients recruited for risk factor
analysis. 120 patients were male and 123 patients were
female. 33 out of 243 patients had congenital heart
disease. Most had an atrial septal defect or patent ductus
arteriosus. The remainder had valvular heart disease.
The distribution of various valvular or congenital heart
diseases is shown in Table 1.
The age of the patients ranged from 37 to 82 with
mean age 55.7 ± 10.4. Symptom of chest pain, either
typical or atypical for coronary ischemia, was present
in 51 (21.0%) patients. 23 (9.5%) patients had
hypertension and 14 (5.8%) had diabetes mellitus. 81
(33.3%) patients had history of smoking, either exsmoker or current smoker. Hyperlipidemia, as
previously defined, was present in 55 (22.6%) patients.
The risk factor profiles among the study group is shown
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in Table 2.
Twenty-three (9.7%) out of 243 patients had CAD
as demonstrated by coronary angiography. Fourteen of
them were male and nine were female patients. Risk
factors comparisons between patients with or without
coronary artery disease are shown in Table 3. There
was no preponderance of either sex for coronary artery
disease. The mean age of patients with coronary artery
disease was slightly but significantly older than that of
patients without coronary artery disease (60.0 ± 9.3 vs
55.3 ± 10.5 respectively, p=0.029). Hypertension
(p=0.004), smoking (p=0.044) and hyperlipidemia
(p<0.001) were significant predictors for coronary artery
disease but neither history of chest pain nor diabetes
mellitus were significant predictors. After excluding
patients with aortic valve disease, both chest pain and
diabetes mellitus were not significant predictors for
CAD. Using multivariate analysis, hyperlipidemia
(p<0.001) was the only independent significant risk
factor to predict the presence of coronary artery disease.
Among those patients with coronary artery
disease, defined as more than 50% stenosis in any one
of epicardial coronary arteries, 11 patients underwent
CABG. By comparing the risk factor profiles between
patients with or without CABG done, hyperlipidemia

Table 1. Distributions of various valvular or congenital
heart disease
Diseases
No. of patients (%)
Total
243
Mitral valve
90 (37.0)
Aortic valve
86 (35.4)
Mixed mitral and aortic valves
32 (13.2)
Atrial septal defect
21 (8.6)
Patent ductus arteriosus
9 (3.7)
Others
5 (2.1)

Table 2. Risk factor profiles of the study group
Risk factor
Sex (M:F)
120:123
Chest pain, no. of case (%)
51 (21.0)
Hypertension, no. of case (%)
23 (9.5)
Diabetes mellitus, no. of case (%)
14 (5.8)
Smoking, no. of case (%)
81 (33.3)
Hyperlipidemia, no. of case (%)
55 (22.6)
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(p<0.001) was the only significant predictor of patients
requiring CABG, as shown in Table 3.
By using CABG and coronary artery disease as
two different outcome measures, the correlation
between number of risk factors and these two outcomes
is shown in Table 4. No patient with none of these risk
factors had coronary artery disease or had CABG done.
The Pearson correlation coefficient between number of
risk factors and proportion of patients having CAD is
0.42 (p<0.001), i.e. patients with more risk factors had
higher probability of CAD or CABG. The mean number
of risk factors in patients without CAD was significantly
less than that of in patients with CAD (0.79 ± 0.88 vs
2.17 ± 0.89, p<0.001). By means of the simplified
coronary scoring system, the number of cardiovascular
risk factors was significantly correlated with the
severity of coronary artery disease (Spearman's r =
0.386, p<0.001).

The incidence of CAD or CABG in different age
groups is shown in Table 5. No patient with CAD was
younger than the age of 40 and no patient less than age
50 required CABG. The incidences of CAD and CABG
were higher in the more elderly group of patients. The
proportion of patients with CAD rose from 5.6% in the
age <50 group to 9.6% in the age <70 group and that of
CABG rose from 2.7% in the age <60 to 3.5% in the
age <70 group.

Discussion
In this retrospective analysis, we have
demonstrated clinically that traditional risk factors for
coronary artery disease including age, hypertension,
smoking and hyperlipidemia can predict the presence
of significant coronary artery disease in patients with

Table 3. Comparison of risk factors profiles between patient with or without coronary artery disease, and with or without
CABG
Risk factor
CAD
No CAD
P value
CABG
No CABG
P value
Sex (M:F)
14:9
111:109
NS
3:8
117:115
NS
Age (years)
60.0 ± 9.3
55.3 ± 10.5
0.029
58.8 ± 10.8
55.6 ± 10.4
NS
Chest pain, no. of case (%)
8 (34.8)
43 (19.5)
NS
4 (36.4)
47 (20.3)
NS
Hypertension, no. of case (%)
6 (26.1)
17 (7.7)
0.004
2 (18.2)
21 (9.1)
NS
Diabetes mellitus, no. of case (%)
3 (13.0)
11 (5.0)
NS
1 (9.1)
13 (5.6)
NS
Smoking, no. of case (%)
12 (52.2)
69 (31.3)
0.044
5 (45.5)
76 (32.8)
NS
Hyperlipidemia, no. of case (%)
21 (91.3)
34 (18.1)
< 0.001
11 (100)
44 (19.0)
< 0.001

Table 4. Correlation between number of risk factors and proportion of patients had CAD or CABG
No. of risk factor
No. of patients
No. of patients with CAD (%)
No. of patients with CABG (%)
0
100
0 (0)
0 (0)
1
81
5 (6.2)
2 (2.5)
2
47
11 (23.4)
6 (12.8)
> or = 3
15
7 (46.7)
3 (20.0)
Risk factors include Age >65, Smoker, DM, HT, Chest Pain and Hyperlipidemia.

Table 5. Proportion of patients with CAD in different age group
Age
No. of patients
No. of patients with CAD (%)
<40
15
0 (0)
<50
72
4 (5.6)
<60
147
11 (7.5)
<70
198
19 (9.6)
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No. of patients with CABG (%)
0 (0)
0 (0)
4 (2.7)
7 (3.5)
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either congenital or valvular heart disease awaiting
cardiac surgery. Moreover, with more risk factors, the
chance of having co-existing coronary artery disease
was higher, consistent with the additive properties of
these common risk factors. However, neither a history
of chest pain nor diabetes mellitus was significant
predictor for coronary artery disease in our cohort of
patients. We have confirmed that the overall prevalence
of coronary artery disease in our patient group was
9.6%, which was much lower than that seen in western
countries, generally reported to be 20-30%.3
Chest pain is a well known to be a poor predictor
of the presence of coronary artery disease in patients
with valvular heart disease. Conversely, the lack of pain
does not predict the absence of disease. For example,
one study suggested that coronary artery disease was
very rare in patients with aortic stenosis who did not
have chest pain, 10 but others had found significant
coronary stenosis in as many as 25% of such patients
who were free of chest pain.11,12 Our results also suggest
that symptom of chest pain is not a reliable predictor of
coronary artery disease. It is surprising to note that
diabetes mellitus is not one of the reliable predictors
for coronary artery disease. The prevalence of noninsulin dependent diabetes mellitus is high in China, as
high as 20% in those aged >70 years.13 On the other
hand, the traditional cardiovascular risk factors
including diabetes mellitus are only present in 50% of
patients with coronary artery disease in China.9 New
coronary risk factors like hyperhomocysteinaemia may
be important in improving the predictability of these
traditional risk factors.17
Hyperlipidemia is the only reliable predictor for
coronary artery disease that required coronary artery
bypass grafting in patients with congenital or valvular
heart disease requiring cardiac surgery in our study. In
western countries, the reported prevalence of
hyperlipidemia in patients with co-existing coronary and
valvular heart disease was 33%.20 In those who had no
CAD, the prevalence was 6%. The importance of
hyperlipidemia in the development of atherosclerosis
is well proven. There is concern about the rising mean
cholesterol level in the developed areas of Asia like
Hong Kong, Taiwan and Singapore as the incidence of
coronary artery disease rises almost linearly with the
cholesterol level.13 In our study, 22% of patients had
hyperlipidemia.
Using CABG as one of the outcome
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measurements is much more clinically meaningful as
revascularization may not be necessary in patient with
borderline coronary artery lesion, e.g. a 50% lesion in a
distal artery. The purpose of coronary angiography in
patients with valvular or congenital heart disease is to
detect co-existing coronary artery lesions that may not
be clinically obvious but that may require
revascularization. It is logical to bypass the significant
lesions detected at the same time as performing valve
replacement or correction of a congenital defect.
Careful selection of patients with congenital or
valvular heart disease to undertake coronary
angiography as part of routine preoperative evaluation
is vital as this invasive investigation is not free of
complication. From the Registry of the Society for
Cardiac Angiography and Interventions, the reported
mortality of coronary angiography was 0.1%,
myocardial infarction 0.06%, cerebral ischemia 0.07%,
vascular complication 0.46% and contrast reactions
0.23%.14 In our study, 2 (0.8%) patients had vascular
complications, 1 (0.4%) patient had cerebral ischemia,
1 (0.4%) patient had acute renal failure and 1 (0.4%)
patient had a severe allergic reaction to contrast agent
and required admission to intensive care unit. No patient
died after coronary angiography in our cohort.
Unfortunately, none of the above patients who had
complications following angiography had coronary
artery disease. This indicates how important it is to
correctly identify those patients requiring non-coronary
surgery who are at risk of coronary artery disease and
who need to have coronary angiography done as part of
the preoperative evaluation. A variety of non-invasive
methods have been investigated over the years as
possible substitutes for coronary angiography as a means
of detecting coronary artery disease in combination with
valve or congenital heart disease. Exercise testing is in
general not satisfactory as the ECG changes are often
uninterpretable and the exercise tolerance of these
patients is often very limited. Myocardial perfusion
scanning with thallium has not shown a sufficient degree
of diagnostic accuracy to be clinically useful.15,16 Stress
echocardiography may be more useful.18,19 However, at
the present time, coronary arteriography is the most
reliable way of demonstrating coronary disease. The
other techniques do not seem to be any more accurate
than predictions based on risk factors.3,5
Useful information can be derived from our study
for selecting those patients, especially Chinese patients,
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with valvular or congenital heart disease who should
undergo coronary angiography prior to cardiac surgery.
Coronary angiography should not be obligatory in
patients with age <50 or patients who have no known
cardiovascular risk factors regardless of age and sex.
Patients with hyperlipidemia should have a relatively
lower threshold for coronary angiography even though
the clinical likelihood is not high, as hyperlipidemia is
a strong independent predictor for coronary artery
disease that may require CABG. Patients with only 1
risk factor (age >65, smoking, diabetes mellitus,
hypertension, chest pain and hyperlipidemia) have a
6.2% chance of having co-existing coronary artery
disease while the presence of two risk factors increases
the chance to 23.4%. Patients with 3 or more risk factors
have a 46.7% chance of having coronary artery disease.
Therefore patients with 2 or more risk factors should
have coronary angiography done as part of routine
preoperative evaluation. For patients with single risk
factor, other modality of non-invasive investigation may
be able to provide further information to assess the need
for coronary angiography.
The current cardiac surgical advice, based on the
recommendation from ACC/AHA Task Force, demands
coronary angiography in most patients over the age of
40 prior to valve or congenital heart surgery. Such an
approach has never been proven to be scientifically or
practically sound, and angiography is not without risk.
In our study, risk factor analysis seems to be able to
select the appropriate patients who may have higher
chance of co-existing coronary artery disease and who
should have coronary angiography preoperatively.
Therefore, the combined risks of investigation and
surgery can then be lower in patients who have relatively
lower chance of coronary artery disease. In this era of
cost-constraints, the strategy of performing coronary
angiography as a routine pre-operative investigation to
look for coronary artery disease is definitely
unacceptable given the low likelihood of detecting
disease in this study population. Risk factor analysis as
in our study seems to be a more cost-effective method
in proper selection of patients for coronary angiography.
When considering the cost of various non-invasive
investigations e.g. thallium scan or stress
echocardiogram, risk factor analysis is again the method
of choice. However, in borderline cases, e.g. patients
with only one risk factor, these investigations may be
helpful. More sensitive and specific non-invasive ways
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to detect clinically significant coronary disease would
solve the above issues. Magnetic resonance angiography
may be the best investigation in the future.

Limitation
This is a retrospective analysis. The underlying
rationale for deciding which patients need coronary
angiography may change with time. A prospective study
using predefined rationale will be the best approach to
assess how useful is risk factor analysis in detecting
coronary lesion in patients with valvular or congenital
heart disease. Moreover, the absolute number of patients
with coronary artery disease was small making
statistical analysis less reliable, especially in analysing
those patients who had CABG done.

Conclusion
Hyperlipidemia is the best predictor of coronary
artery disease that requires CABG irrespective of age,
sex, history of smoking, chest pain, hypertension or
diabetes mellitus in patients with either congenital or
valvular heart disease undergoing corrective surgery or
valvular replacement. Routine preoperative coronary
angiography is unnecessary in patients without risk
factors for coronary artery disease. Risk factor analysis
can effectively select the high-risk patients who really
need coronary angiography before surgery.
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